Stock NVNO ENVVENO MEDICAL CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Calendar enVVeno Medical Corporation

Equities

NVNO

US29415J1060

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-04-29 EDT 		5-day change 1st Jan Change
5.22 USD +0.77% Intraday chart for enVVeno Medical Corporation +6.31% +1.56%
04-16 EnVVeno Medical Corporation Announces Additional Topline Efficacy Data from the VenoValve U.S. Pivotal Trial to Be Presented at the 46th Annual Charing Cross Symposium on April 24, 2024 CI
04-09 EnVVeno Medical Corporation Appoints Andrew Cormack as Its Chief Commercial Officer CI

Chart calendar enVVeno Medical Corporation

2aa2e.RJZp2kf8RZnooBjny92Fe1B0T30wU8v5dZ53DnMvtt8.FvACoyrPd_qryiCuuYjqMj0gdhJIAPnMMs08XxBV5boT8juuGLgt2orMew~cde70e6985e9f63ef6bb3bb2b5d8d4ac

Upcoming events on enVVeno Medical Corporation

2024-11-06 Q3 2024 Earnings Release (Projected)
2025-05-04 Q1 2025 Earnings Release (Projected)

Past events on enVVeno Medical Corporation

2024-04-28 Q1 2024 Earnings Release (Projected)
2024-04-23 Charing Cross International Symposium - Dr. David Dexter
2024-03-06 13:30 American Venous Forum
2023-12-04 Annual General Meeting
2023-11-15 VEITH Symposium
2023-10-26 08:05 Q3 2023 Earnings Release
2023-10-25 12:00 Investor Ask the CEO Conference
2023-08-01 Q2 2023 Earnings Release (Projected)
2023-07-18 15:00 Investor Meeting - Key Opinion Leader
2023-07-13 12:00 Summer Spotlight Series Investor Conference
2023-05-01 08:00 Q1 2023 Earnings Release
2023-03-08 09:10 Cowen Health Care Conference
2023-03-01 Q4 2022 Earnings Release
2023-01-19 13:00 Virtual Investor 2023 Companies to Watch
2022-11-29 Annual General Meeting
2022-11-10 15:05 Q3 2022 Earnings Release
2022-09-29 14:00 Ladenburg Thalmann Healthcare Conference - Fireside Chat
2022-09-21 16:30 Business Update Call
2022-09-12 07:00 H.C. Wainwright Global Investment Conference
2022-08-03 16:45 Interim 2022 Earnings Release

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		0,03
0,03
0.77%		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBITDA
Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBIT
Million USD		Released
Forecast
Spread 		-7,68
-7,76
1.1%		-9,14
-7,04
-29.76%		-16,9
-12,6
-34.17%		-24,9
-25,2
1.14%		-25,2
-26,7
5.48%
-25,8

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-7,63
-7,72
1.21%		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

Net income
Million USD		Released
Forecast
Spread 		-7,63
-7,72
1.21%		-9,74
-6,70
-45.41%		-16,5
-12,4
-33.4%		-24,7
-25,3
2.46%		-23,5
-26,1
9.8%
-26,1

EPS
USD		Released
Forecast
Spread 		-12,0
-12,3
2.04%		-7,54
-0,34
-2117.65%		-1,90
-1,37
-38.69%		-2,20
-2,21
0.45%		-1,91
-2,07
7.73%
-1,40

Announcement Date18/03/2031/03/2128/03/2202/03/2329/02/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00


0,00


0,00


0,00


0,60

EBIT
Million USD		Released
Forecast
Spread 		-8,99
-4,10
-119.32%		-5,34
-3,72
-43.41%		-6,99
-3,94
-77.31%		-6,15
-5,98
-2.86%		-6,46
-6,75
4.3%		-6,80
-6,38
-6.54%		-6,81
-6,55
-4.03%		-5,35
-6,44
16.94%		-6,28
-6,65
5.59%
-6,60


-6,64


-5,94


-6,65


-6,89

Net income
Million USD		Released
Forecast
Spread 		-8,99
-4,02
-123.58%		-5,33
-3,78
-41.01%		-7,06
-3,99
-76.99%		-6,10
-6,04
-0.94%		-6,18
-6,80
9.12%		-6,39
-6,44
0.75%		-6,47
-6,61
2.06%		-5,00
-6,49
22.94%		-5,65
-6,71
15.81%
-6,66


-6,70


-6,00


-6,71


-6,95

EPS
USD		Released
Forecast
Spread 		-0,94
-0,33
-184.85%		-0,47
-0,29
-62.07%		-0,63
-0,33
-90.91%		-0,54
-0,52
-3.85%		-0,55
-0,57
3.51%		-0,57
-0,48
-18.75%		-0,58
-0,49
-18.37%		-0,45
-0,48
6.25%		-0,32
-0,46
30.43%
-0,40


-0,36


-0,31


-0,34


-0,33

Announcement Date28/03/2229/04/2203/08/2227/10/2202/03/2328/04/2331/07/2326/10/2329/02/24-----

Upcoming sector events for enVVeno Medical Corporation

2024-04-30 DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected)
2024-04-30 PROTAGONIST THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected)
2024-04-30 EDITAS MEDICINE, INC.: Q1 2024 Earnings Release (Projected)
2024-04-30 AZENTA, INC.: Q2 2024 Earnings Release (Projected)
2024-05-01 06:30 UNITED THERAPEUTICS CORPORATION: Q1 2024 Earnings Release
2024-05-01 06:30 BIO-TECHNE CORPORATION: Q3 2024 Earnings Release
2024-05-01 07:00 ALKERMES PLC: Q1 2024 Earnings Release
2024-05-01 VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release
2024-05-01 CELLDEX THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected)
2024-05-01 MIRUM PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected)
More events

Past sector events for enVVeno Medical Corporation

Today CRISPR THERAPEUTICS AG: Q1 2024 Earnings Release (Projected)
2024-04-29 16:05 QIAGEN N.V.: Q1 2024 Earnings Release
2024-04-29 16:01 MORPHOSYS AG: Q1 2024 Earnings Release
2024-04-28 BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-28 JOINN LABORATORIES(CHINA)CO.,LTD.: Q1 2024 Earnings Release
2024-04-27 SINO BIOLOGICAL,INC.: Q1 2024 Earnings Release
2024-04-26 GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release
2024-04-26 01:00 BB BIOTECH AG: Q1 2024 Earnings Release
2024-04-25 BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release
2024-04-25 PHARMARESOURCES (SHANGHAI) CO., LTD.: Q1 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. NVNO Stock
  4. Calendar enVVeno Medical Corporation